Sunesis Pharmaceuticals Reviews

Rating Trends
Recommend to a friend
Approve of CEO
Sunesis Pharmaceuticals President, CEO, and Director Dan Swisher Jr.
Dan Swisher Jr.
4 Ratings
  • Former Employee

    • Work/Life Balance
    • Culture & Values
    • Senior Management
    Former Employee - Anonymous Employee
    Former Employee - Anonymous Employee
    Approves of CEO


    Excellent company to work for . Executive branch kind and caring individuals.


    I have nothing negative to say about the company.

Sunesis Pharmaceuticals Awards & Accolades

Let us know if we're missing any workplace or industry recognition – Add an award

Additional Info

Unlock Profile
Headquarters South San Francisco, CA
Size 1 to 50 Employees
Founded Unknown
Type Company - Public (SNSS)
Industry Biotech & Pharmaceuticals
Revenue $5 to $10 million (USD) per year

Sunesis builds drugs in miniature first before it builds them in full scale. The biotech firm's method involves building small drug fragments and then examining their protein-binding ability and potential for development. Once a fragment shows potential, Sunesis then builds a larger therapeutic compound based upon its model. Its drug candidates target various forms of cancer. Its lead candidate SNS-595 is in clinical trials to evaluate its effect on ovarian cancer and acute myeloid leukemia. Its other candidates include SNS-314, which is being studied for its effect ... More

Work at Sunesis Pharmaceuticals? Share Your Experiences

Sunesis Pharmaceuticals

Click to Rate